CRE CRE
Company Profile ↓Company Overview
CRE (CRE) is a publicly traded company listed on with a market capitalization of $5.20M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 10.5% CAGR over the past five years.
Trades at an undemanding P/E of 0.8.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $130.93M (+26.1% YoY); net profit $5.28M.
- Trailing 12 Months Year-on-year growth — revenue +26.1%, earnings -17.6%.
- 5-Year Trend Long-term compounding — revenue CAGR 10.5%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 10.53% |
| 1 Year: | 26.11% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | -17.58% |
Stock Price Performance
| 1 Year: | -96.58% |
| 6 Months: | -23.07% |
| 3 Months: | -33.55% |
| 1 Month: | -21.19% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)46.00 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 10.5% over 5 years.
- Generates positive free cash flow.
CONS
- Trading 97.0% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 96.96M | 115.29M | 103.82M | 130.93M |
| Cost of Revenue | - | 73.85M | 68.27M | 61.43M | 76.05M |
| Gross Profit | - | 23.11M | 47.01M | 42.39M | 54.88M |
| Operating Expenses | - | 37.65M | 37.94M | 33.96M | 49.02M |
| Operating Income | - | -14.54M | 9.07M | 8.43M | 5.86M |
| EBITDA | - | -12.77M | 10.58M | 9.56M | 7.54M |
| Interest Expense | - | 773.50K | 124.02K | 316.72K | 250.94K |
| Pretax Income | - | -14.94M | 9.28M | 8.53M | 6.91M |
| Tax Provision | - | -2.67M | 1.50M | 2.13M | 1.63M |
| Net Income | - | -12.28M | 7.78M | 6.40M | 5.28M |
| Diluted EPS | 0.83 | -6.15 | 3.85 | 3.17 | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 74.66M | 71.43M | 57.05M | 116.02M |
| Current Assets | - | 37.32M | 48.13M | 42.44M | 85.18M |
| Cash & Equivalents | - | 848.13K | 14.75M | 13.85M | 54.71M |
| Inventory | - | - | - | - | - |
| Receivables | - | 30.40M | 29.55M | 18.86M | 22.58M |
| Total Liabilities | - | 78.85M | 67.90M | 47.14M | 64.58M |
| Current Liabilities | - | 66.15M | 65.96M | 43.50M | 54.09M |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 45.58M | 22.36M | 15.35M | 28.59M |
| Total Equity | - | -4.19M | 3.53M | 9.90M | 51.44M |
| Shares Outstanding | - | 2.00M | 2.00M | 2.01M | 2.01M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -13.86M | 5.48M | 6.98M | 11.54M |
| Investing Cash Flow | - | -272.14K | -191.00K | -134.71K | -708.34K |
| Financing Cash Flow | - | -5.34M | 8.68M | -7.73M | 30.10M |
| Capital Expenditure | - | -272.14K | -191.00K | -134.71K | -717.34K |
| Free Cash Flow | - | -14.13M | 5.29M | 6.85M | 10.82M |
| Net Change in Cash | - | -19.47M | 13.97M | -881.02K | 40.93M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 23.8% | 40.8% | 40.8% | 41.9% |
| Operating Margin % | - | -15.0% | 7.9% | 8.1% | 4.5% |
| Net Margin % | - | -12.7% | 6.8% | 6.2% | 4.0% |
| ROE % | - | 293.1% | 220.3% | 64.7% | 10.3% |
| ROCE % | - | -171.0% | 165.7% | 62.3% | 9.5% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CRE
5 Best-Performing Health Care Stocks for August 2026 - NerdWallet
<a href="https://news.google.com/rss/articles/CBMiggFBVV95cUxORWNJcG9GcmpWdVZYbFA3UkpoVFBTV3A3RHJNTzN1a0NRYWIyZi1VamxKVFdpRVIzZzJKZ1dfV3lReHNOOUNWWU5Wdm9XU3Uxb2t4a1VDVmxDd29kaTliT1VpZVFzVkdYM0d3YU1iN2tjUWt6ZzJXLS11b0RBM081dG5R?oc=5" target=…
Cre8 Enterprise Limited Revenue Breakdown – NASDAQ:CRE - TradingView
<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE44cVNrSkMtNXFnSURsUkNvSlpPaFZMbjBVNlpfR0dQd251WWJSUV9za1dUXzdQb2pPcEFLYzFpUW92WFVLN0xKZVZJZU1MR2s5elpiUVItdDM0RjdQbFRLOTZncld4V05faGNPd2QwcDdtNWFJeVE?oc=5" target="_blank">Cre8 Ent…
CRE Stock Whipsaws Higher As Traders Chase Volatility - timothysykes.com
<a href="https://news.google.com/rss/articles/CBMif0FVX3lxTE5uMTJWWl9RcmtYTmpWTDRTN1lkWDJKSFpEcEZTQU1JZktkNVl5aVVWYlBpdGtMYmRCcHJOaDF4UGlwc3loOW55XzI1S1oxNUFOQzBuekFSRi1JNHpTdEs1RVZnSWJON0xUOXBBZXVFakZIMUNGQW1lMUZ2Z1U5TWs?oc=5" target="_bla…
Mechanics Bancorp (MCHB) Stock Finds Support In Cost Cuts As CRE Questions Persist - Sahm
<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxOckgtbms0QndGdVV3Y0tIQ21fbU5qVUtpV1l3Z3ZRRDBuOE5SRWh5OEdvQ1dwczhfLU5XNnJUcHR1N1JMX2RsUE1vT1pxclVpS29hM2V4Z2lVNmVTMC1NWGlUaWJmaTZJN0hNdllvMGhlZ3NJUHlEZWlyT2RQX0RfajE4LW90T3ozNjVsOT…
Cre8 Enterprise (CRE) surges as Nasdaq compliance overhang lifts after reverse split - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxNZFZaOVpqZURDeFlsQ3VQdkR5dGRpTHlib3NRSF9XOGVYSmgtRWtkMGUzcjRHeFo4VUp5UjZheEZ1dVBPUUdIVXNZMWZ3OEZSMk9aejM5X0RDUWpYZTlqaExFWTZCME9hSDhMUlluS1A0NnYweXRwQ0hNUG0zMm9nOVJ6MWlSLWNLUGlJdV…
12 Industrials Stocks Moving In Wednesday's After-Market Session - Benzinga
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxOZG1JbmE5NFZZZlhZZVNYSFRZUUl6anlISU1kbjdFMVlCWlJ6YXlRMXI4N0Q1bEF0c0RYcTZEV0RXaFVTRHdvbjFZQjZwNWxrcWFyNkVUWmtQVm16THBlVnZWSXBDQmFBWEJ5bXlJVmRJQ3I4a2ZPWGliUDFUYlBtajRlUVdsc0NubXh5OH…
CRE — Frequently Asked Questions
What is the current share price of CRE?
As of 2026-08-05 17:25 PDT, CRE trades at $2.58 on NASDAQ/NYSE. Its 52-week range is $2.13 to $87.48.
What is the market capitalisation of CRE?
CRE has a market capitalisation of $5.20M on NASDAQ/NYSE.
What is the P/E ratio of CRE?
CRE trades at a trailing price-to-earnings (P/E) ratio of 0.81. Its price-to-book (P/B) ratio is 0.10.
What is the return on equity (ROE) of CRE?
CRE has a return on equity (ROE) of 10.26%. Its return on capital employed (ROCE) is 9.47%.
Is CRE a good stock to buy?
This page provides a data-driven analysis of CRE, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.